Mechanistic features of recombination in HIV

AIDS Reviews

Volumn 7, Issue 2, 2005, Pages 92-102

  Galetto, Román ^a   Negroni, Matteo ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Genetic variability; HIV; Molecular mechanism; Recombination

Indexed keywords

GENOMIC RNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DNA STRAND; DNA SYNTHESIS; EPIDEMIC; EVOLUTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROTEIN SECONDARY STRUCTURE; RETROVIRUS; REVIEW; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINATION;

EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HUMANS; REASSORTANT VIRUSES; RECOMBINATION, GENETIC;

EID: 23144449384     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Hahn B, Shaw G, De Cock K, Sharp P. AIDS as a zoonosis: scientific and public health implications. Science 2000;287:607-14.
2. Gao F, Bailes E, Robertson D, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-41.
3. Robertson D, Anderson J, Bradac J, et al. HIV-1 Nomenclature Proposal. In Human Retroviruses and AIDS 1999. Kuiken C, Foley B, Hahn B, et al. (eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 1999; 492-505.
4. Robertson D, Anderson J, Bradac J, et al. HIV-1 nomenclature proposal. Science 2000;288:55-6.
5. Thomson M, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002;2:461-71.
6. Vidal N, Peeters M, Mulanga-Kabeya C, et al. Unprecedented degree of HIV type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000;74:10498-507.
7. Peeters M, Toure-Kane C, Nkengasong J. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. Aids 2003;17:2547-60.
8. Peeters M, Gueye A, Mboup S, et al. Geographical distribution of HIV-1 group O viruses in Africa. Aids 1997;11:493-8.
9. Ayouba A, Souquieres S, Njinku B, et al. HIV-1 group N among HIV-1-seropositive individuals in Cameroon. Aids 2000;14:2623-5.
10. Damond F, Worobey M, Campa P, et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses 2004;20:666-72.
11. Rambaut A, Posada D, Crandall K, Holmes E. The causes and consequences of HIV evolution. Nat Rev Genet 2004;5:52-61.
12. The Circulating Recombinant Forms (CRFs). Los Alamos National Laboratory. HIV Sequence Database. (last accessed, March 2005). http://hiv-web.lanl.gov/content/hiv-db/CRFs/CRFs.html
13. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002;29:184-90.
14. Takehisa J, Zekeng L, Ido E, et al. HIV type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-20.
15. Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O HIV type 1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7368-75.
16. McVean G, Awadalla P, Fearnhead P. A coalescent-based method for detecting and estimating recombination from gene sequences. Genetics 2002;160:1231-41.
17. Vogt P. Genetically stable reassortment of markers during mixed infection with avian tumor viruses. Virology 1971;46:947-52.
18. Hu W, Temin H. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990: 87:1556-60.
19. Clavel F, Hoggan M, Willey R, Strebel K, Martin M, Repaske R. Genetic recombination of HIV. J Virol 1989;63:1455-9.
20. Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
21. Preston B, Poiesz B, Loeb L. Fidelity of HIV-1 reverse transcriptase. Science 1988;242:1168-71.
22. Hu W, Temin H. Retroviral recombination and reverse transcription. Science 1990;250:1227-33.
23. Mansky L, Temin H. Lower in vivo mutation rate of HIV type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69:5087-94.
24. Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol Rev 1999;168:51.
25. Jung A, Maier R, Vartanian J, et al. Multiply infected spleen cells in HIV patients. Nature 2002;418:144.
26. Jost S, Bernard M, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med 2002;347:731-6.
27. Fang G, Weiser B, Kuiken C, et al. Recombination following superinfection by HIV-1. Aids 2004;18:153-9.
28. Ramos A, Hu D, Nguyen L, et al. Intersubtype HIV type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002;76:7444-52.
29. Levy D, Aldrovandi G, Kutsch O, Shaw G. Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci USA 2004;101:4204-9.
30. McDonald D, Wu L, Bohks S, KewalRamani V, Unutmaz D, Hope T. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003;300:1295-7.
31. Berger E, Doms R, Fenyo E, et al. A new classification for HIV-1. Nature 1998;39:240.
32. Paillart J, Shehu-Xhilaga M, Marquet R, Mak J. Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol 2004;2:461-72.
33. St Louis D, Gotte D, Sanders-Buell E, et al. Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of HIV type 1 can recombine and initiate a spreading infection in vitro. J Virol 1998;72:3991-8.
34. Anderson J, Bowman E, Hu W. Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol 1998;72:1195-1202.
35. Yu H, Jetzt A, Ron Y, Preston B, Dougherty J. The nature of HIV type 1 strand transfers. J Biol Chem 1998;273:28384-91.
36. Zhang J, Tang L, Li T, Ma Y, Sapp C. Most retroviral recombinations occur during minus-strand DNA synthesis. J Virol 2000; 74:2313-22.
37. Jetzt A, Yu H, Klarmann G, Ron Y, Preston B, Dougherty J. High rate of recombination throughout the HIV type 1 genome. J Virol 2000;74:1234-40.
38. Boone L, Skalka A. Strand Displacement Synthesis by Reverse Transcriptase. In Reverse Transcriptase. Skalka A and Goff S. (eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993;119-33.
39. Hu W, Pathak V, Temin H. Role of Reverse Transcriptase in Retroviral Recombination. In Reverse Transcriptase. Skalka A and Goff S. (eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993;251-74.
40. Magiorkinis G, Paraskevis D, Vandamme A, Magiorkinis E, Sypsa V, Hatzakis A. In vivo characteristics of HIV type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity. J Gen Virol 2003;84:2715-22.
41. Junghans R, Boone L, Skalka A. Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol 1982: 43:544-54.
42. Junghans R, Boone L, Skalka A. Retroviral DNA H structures: displacement assimilation model of recombination. Cell 1982;30:53-62.
43. Huber H, McCoy J, Seehra J, Richardson C. HIV 1 reverse transcriptase. J Biol Chem 1989;264:4669-78.
44. Hottiger M, Podust V, Thimmig R, McHenry C, Hubscher U. Strand displacement activity of the HIV type 1 reverse transcriptase heterodimer and its individual subunits. J Biol Chem 1994;269:986-91.
45. Bowman R, Hu W, Pathak V. Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol 1998;72:5198-206.
46. Vogt P. The genome of avian RNA tumor viruses: a discussion of four models. In Proceedings of the Fourth Lepetit Colloquium: «Possible episomes in eukaryotes». Silvestri L. (ed.). North Holland Publishing Co., Amsterdam 1973;35-41
47. Oyama F, Kikuchi R, Crouch R, Uchida T. Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNaseH is essentially regarded as an endonuclease. J Biol Chem 1989;264:18808-17.
48. Krug M, Berger S. Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Proc Natl Acad Sci USA 1989;86:3539-43.
49. Wisniewski M, Balakrishnan M, Palaniappan C, Fay P, Bambara R. The sequential mechanism of HIV reverse transcriptase RNaseH. J Biol Chem 2000;275:37664-71.
50. Schultz S, Zhang M, Champoux J. Recognition of internal cleavage sites by retroviral RNaseH. J Vol Biol 2004;344:635-52.
51. Telesnitsky A, Goff S. Two defective forms of reverse transcriptase can complement to restore retroviral infectivity. EMBO J 1993; 12:4433-8.
52. Coffin J. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. Journal of General Virology 1979;42:1-26.
53. Wisniewski M, Balakrishnan M, Palaniappan C, Fay P, Bambara R. Unique progressive cleavage mechanism of HIV reverse transcriptase RNaseH. Proc Natl Acad Sci USA 2000;97:11978-83.
54. Ben-Artzi H, Zeelon E, Amit B, Wortzel A, Gorecki M, Panet A. RNaseH activity of reverse transcriptases on substrates derived from the 5′ end of retroviral genome. J Biol Chem 1993;268:16465-71.
55. Peliska J, Benkovic S. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 1992;258:1112-8.
56. Hu W, Temin H. Effect of gamma radiation on retroviral recombination. J Virol 1992;66:4457-63.
57. DeStefano J, Mallaber L, Rodriguez-Rodriguez L, Fay P, Bambara R. Requirements for strand transfer between internal regions of heteropolymer templates by HIV reverse transcriptase. J Virol 1992; 66:6370-8.
58. DeStefano J, Bambara R, Fay P. The mechanism of HlV reverse transcriptase-catalyzed strand transfer from internal regions of heteropolymeric RNA templates. J Biol Chem 1994;269:161-8.
59. Wu W, Blumberg B, Fay P, Bambara R. Strand transfer mediated by HIV reverse transcriptase in vitro is promoted by pausing and results in misincorporation. J Biol Chem 1995;270:325-32.
60. Levin J, Guo J, Rouzina I, Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog Nucleic Acids Res Mol Biol 2005;80:217-86-.
61. Rodriguez-Rodriguez L, Tsuchihashi Z, Fuentes G, Bambara R, Fay P. Influence of HIV nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J Biol Chem 1995; 270:15005-11.
62. Raja A, DeStefano J. Kinetic analysis of the effect of HIV nucleocapsid protein (NCp) on internal strand transfer reactions. Biochemistry 1999;38:5178-84.
63. DeStefano J. HIV nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch Virol 1995;140:1775-89.
64. Derebail S, Heath M, DeStefano J. Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome. J Biol Chem 2003;278:15702-12.
65. Kim J, Palaniappan C, Wu W, Fay P, Bambara R. Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J Biol Chem 1997;272:16769-77.
66. Negroni M, Buc H. Copy-choice recombination by reverse transcriptases: reshuffling of genetic markers mediated by RNA chaperones. Proc Natl Acad Sci USA 2000;97:6385-90.
67. Roda R, Balakrishnan M, Kim J, Roques B, Fay P, Bambara R. Strand transfer occurs in retroviruses by a pause-initiated two-step mechanism. J Biol Chem 2002;277:46900-11.
68. Moumen A, Polomack L, Unge T, Veron M, Buc H, Negroni M. Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA. J Biol Chem 2003;278:15973-82.
69. Negroni M, Buc H. Recombination during reverse transcription: an evaluation of the role of the nucleocapsid protein. J Mol Biol 1999;286:15-31.
70. Gao W, Cara A, Gallo R, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit HIV type 1 replication. Proc Natl Acad Sci USA 1993;90:8925-8.
71. Pfeiffer J, Topping R, Shin N, Telesnitsky A. Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol 1999;73:8441-7.
72. Svarovskaia E, Delvilks K, Hwang C, Pathak V. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol 2000;74:7171-8.
73. Perno C, Yarchoan R, Cooney D, et al. Inhibition of HIV (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′,3′-dideoxynucleosides. J Exp Med 1988;168:1111-25.
74. O'Brien W, Namazi A, Kalhor H, Mao S, Zack J, Chen I. Kinetics of HIV type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 1994; 68:1258-63.
75. Balakrishnan M, Fay P, Bambara R. The kissing hairpin sequence promotes recombination within the HIV-1 5′ leader region. J Biol Chem 2001;276:36482-92.
76. Moumen A, Polomack L, Roques B, Buc H, Negroni M. The HIV-1 repeated sequence R as a robust hot-spot for copy-choice recombination. Nucleic Acids Res 2001;29:3814-21.
77. Suo Z, Johnson K. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry 1997;36:12459-67.
78. Galetto R, Moumen A, Giacomoni V, Veron M, Charneau P, Negroni M. The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo. J Biol Chem 2004;279:36625-32.
79. Roda R, Balakrishnan M, Hanson M, et al. Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination. J Biol Chem 2003;278:31536-46.
80. Klasens B, Huthoff H, Des A, Jeeninga R, Berkhout B. The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta 1999;1444:355-70.
81. Hong M, Harbron E, O'Connor D, et al. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer. J Mol Biol 2003;325:1-10.
82. Beltz H, Azoulay J, Bernacchi S, et al. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7. J Mol Biol 2003;328:95-108.
83. Beltz H, Piemont E, Schaub E, et al. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7. J Mol Biol 2004;338:711-23.
84. Heilman-Miller S, Wu T, Levin J. Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein. J Biol Chem 2004;279:44154-65.
85. Kanevsky I, Chaminade F, Ficheux D, et al. Specific interactions between HIV-1 nucleocapsid protein and the TAR element. J Mol Biol 2005;348:1059-77.
86. Zhuang J, Jetzt A, Sun G, et al. HIV type 1 recombination: rate, fidelity, and putative hot spots. J Virol 2002;76:11273-82.
87. An W, Telesnitsky A. Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a HIV type 1 vector. J Virol 2002;76:7897-902.
88. Pfeiffer J, Telesnitsky A. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol 2001;75:11263-74.
89. Zhang J, Temin H. Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science 1993;259:234-8.
90. Zhang J, Temin H. Retrovirus recombination depends on the length of sequence identity and is not error prone. J Virol 1994;68:2409-14.
91. Liu S, Mittler J, Nickle D, et al. Selection for HIV type 1 recombinants in a patient with rapid progression to AIDS. J Virol 2002; 76:10674-84.
92. Shriner D, Rodrigo A, Nickle D, Mullins J. Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004;167:1573-83.
93. Najera R, Delgado E, Perez-Alvarez L, Thomson M. Genetic recombination and its role in the development of the HlV-1 pandemic. Aids 2002;16(Suppl 4):S3-16.
94. Shankarappa R, Margolick J, Gange S, et al. Consistent viral evolutionary changes associated with the progression of HIV type 1 infection. J Virol 1999;73:10489-502.
95. Molla A, Korneyeva M, Gao Q, et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med 1996;2:760-6.
96. Finzi D, Blankson J, Siliciano J, et al. Latent infection of CD4+ T-cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999;5:512-7.
97. Martinez-Picado J, DePasquale M, Kartsonis N, et al. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000;97:10948-53.
98. Larder B, Kellam P, Kemp S. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 1993;365:451-3.
99. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002;296:2354-60.
100. Moore J, Parren P, Burton D. Genetic subtypes, humoral immunity, and HIV type 1 vaccine development. J Virol 2001;75:5721-9.
101. Seaman M, Xu L, Beaudry K, et al. Multiclade HIV type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J Virol 2005;79:2956-63.
102. Van der Groen G, Nyambi P, Beirnaert E, et al. Genetic variation of HIV type 1: relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998;14(Suppl 3):S211-221.
103. Letvin N, Huang Y, Chakrabarti B, et al. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J Virol 2004;78:7490-7.
104. Chen B, Vogan E, Gong H, Skehel J, Wiley D, Harrison S. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005;433:834-41.
105. Burton D, Barbas C 3rd, Persson M, Koenig S, Chanock R, Lerner R. A large array of human monoclonal antibodies to type 1 HIV from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991;88:10134-7.
106. Barbas C 3rd, Bjorling E, Chiodi F, et al. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci USA 1992;89:9339-43.
107. Burton D, Pyati J, Koduri R, et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994;266:1024-7.
108. Roben P, Moore J, Thali M, Sodroski J, Barbas C 3rd, Burton D. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize HIV type 1. J Virol 1994;68:4821-8.
109. Cho M, Lee M, Chen C, Matthews T, Martin M. Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary HIV type 1 isolate. J Virol 2000;74:9749-54.
110. Pantaleo G, Koup R. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004:10:806-10.
111. Robertson D, Hahn B, Sharp P. Recombination in AIDS viruses. J Mol Evol 1995;40:249-59.